InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.540
+0.030 (1.99%)
At close: Jun 26, 2026, 4:00 PM EDT
1.520
-0.020 (-1.30%)
After-hours: Jun 26, 2026, 5:08 PM EDT
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$380,203
Profits / Employee
-$654,598
Market Cap
6.88M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Biofrontera | 94 |
| China SXT Pharmaceuticals | 75 |
| Sunshine Biopharma | 50 |
| cbdMD | 42 |
| RedHill Biopharma | 13 |
| Gelteq | 8 |
| Sonoma Pharmaceuticals | 8 |
| PRF Technologies | 7 |
INM News
- 23 days ago - InMed regains compliance with Nasdaq continued listing requirements - TheFly
- 23 days ago - InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements - Newsfile Corp
- 5 weeks ago - SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM) - GlobeNewsWire
- 5 weeks ago - InMed Pharmaceuticals Transcript: M&A announcement - Transcripts
- 5 weeks ago - InMed Pharmaceuticals Press release: M&A announcement - Filings
- 5 weeks ago - InMed Pharmaceuticals and Mentari announce merger for migraine prevention - TheFly
- 5 weeks ago - InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies - PRNewsWire
- 5 weeks ago - InMed Pharmaceuticals Amends Preferred Investment Options - Newsfile Corp